Yazan Madanat

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    GERON
    Topic: 
    Steering committee member/honorarium
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Stemline Therapeutics
    Topic: 
    Advisory board member/honorarium
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Bluprint Pharmaceuticals
    Topic: 
    Advisory Board member/Honoraria
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    OncLive
    Topic: 
    Consulting/invited speaker
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    MD Education
    Topic: 
    Consulting/invited speaker
    Date added: 
    04/25/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Rigel Pharmaceuticals
    Topic: 
    Advisory board meeting member
    Date added: 
    04/25/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Novartis
    Topic: 
    Advisotry board meeting member
    Date added: 
    04/25/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Taiho
    Topic: 
    Advisory board meeting member
    Date added: 
    04/25/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Sierra Oncology
    Topic: 
    Advisory board meeting member
    Date added: 
    04/25/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Morphosys
    Topic: 
    Advisory board meeting member
    Date added: 
    04/25/2023
Return to Enduring Activity - Update in Internal Medicine 2023 (RP2304C)